DERM · Journey Medical Corp · Webcasts, Transcripts & Audio
$6.69
+0.08 (+1.21%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, as a result of recurring and historical losses, substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$188.54M
Shares
28.22M
Volume · Oct 5
88.74K
Avg daily vol (3M)
182.66K
Journey Medical Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Journey Medical Corp (DERM), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲19.6%
$18.29M
−$7.53M
'22 Q2
22-08-09
▼17.8%
$16.12M
−$10.08M
'22 Q3
22-11-10
▼8.9%
$15.97M
−$10.64M
'22 Q4
23-03-29
▼47.6%
$12.21M
−$10.14M
'23 Q1
23-05-22
▼6.1%
$17.17M
−$8.36M
'23 Q2
23-08-08
▲114.3%
$34.54M
$16.79M
'23 Q3
23-11-07
▼4.4%
$15.26M
−$2.14M
'23 Q4
24-03-21
▲6.7%
$13.03M
−$10.44M
'24 Q1
24-05-13
▼13.5%
$14.86M
−$3.36M
'24 Q2
24-08-12
▼10.7%
$13.62M
$1.52M
'24 Q4
25-02-05
▲0.8%
$13.14M
−$4.07M
'25 Q1
25-05-14
▲1%
$15.01M
−$3.80M
'25 Q2
25-08-12
▲20.5%
$17.63M
−$2.31M
'25 Q3
25-11-12
▲18.1%
$16.08M
−$1.25M
'25 Q4
26-03-25
▲21.5%
$15.96M
−$2.23M
'26 Q1
26-05-13
LATEST
▲23.3%
$18.51M
−$312,000
'26 Q2
26-08-12
Earnings call
FY26 · Q2
2026-08-12
Journey Medical Corp (DERM) Q2 2026 Earnings Call Transcript
Confident tone
MROSI commercial momentum
Payer access and formulary
Sales force expansion
Revenue
$18.51M
▲ 23.3% YoY Diluted EPS
$-0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Journey Medical Corp (DERM) Q1 2026 Earnings Call Transcript
Confident tone
EMROSI launch momentum and growth
Payer reimbursement and GPO coverage
Refill-to-new prescription ratio and patient retention
Revenue
$15.96M
▲ 21.5% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Journey Medical Corp (DERM) Q4 2025 Earnings Call Transcript
Confident tone
Emrosi launch and commercial uptake
Profitability and adjusted EBITDA
Managed care and market access
Revenue
$16.08M*
▲ 18.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Journey Medical Corp (DERM) Q3 2025 Earnings Call Transcript
Confident tone
Amrozi launch trajectory
Physician and patient feedback
Guidance and outlook
Revenue
$17.63M
▲ 20.5% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Journey Medical Corp (DERM) Q2 2025 Earnings Call Transcript
Confident tone
EMROSI launch performance
Payer access and reimbursement
Accutane generic competition
Revenue
$15.01M
▲ 1% YoY Diluted EPS
$-0.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Journey Medical Corp (DERM) Q1 2025 Earnings Call Transcript
Confident tone
Emrosi launch and product uptake
Clinical data and JAMA Dermatology publication
Dermatology sales force and commercial execution
Revenue
$13.14M
▲ 0.8% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-05
Journey Medical Corp (DERM) Q4 2024 Earnings Call
Revenue
$13.62M*
▼ 10.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-08-12
Journey Medical Corp (DERM) Q2 2024 Earnings Call Transcript
Confident tone
DFD-29 launch readiness and PDUFA
Patent exclusivity runway
Core commercial brands performance
Revenue
$14.86M
▼ 13.5% YoY Diluted EPS
$-0.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Journey Medical Corp (DERM) Q1 2024 Earnings Call Transcript
Confident tone
DFD-29 rosacea launch opportunity
Profitability and cost optimization
Regulatory timeline and FDA review
Revenue
$13.03M
▲ 6.7% YoY Diluted EPS
$-0.53
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
Journey Medical Corp (DERM) Q4 2023 Earnings Call
Revenue
$15.26M*
▼ 4.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Journey Medical Corp (DERM) Q3 2023 Earnings Call Transcript
Revenue
$34.54M
▲ 114.3% YoY Diluted EPS
$0.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Journey Medical Corp (DERM) Q2 2023 Earnings Call Transcript
Revenue
$17.17M
▼ 6.1% YoY Diluted EPS
$-0.46
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-22
Journey Medical Corp (DERM) Q1 2023 Earnings Call Transcript
Revenue
$12.21M
▼ 47.6% YoY Diluted EPS
$-0.57
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Journey Medical Corp (DERM) Q4 2022 Earnings Call Transcript
Revenue
$15.97M*
▼ 8.9% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Journey Medical Corp (DERM) Q3 2022 Earnings Call Transcript
Revenue
$16.12M
▼ 17.8% YoY Diluted EPS
$-0.57
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Journey Medical Corp (DERM) Q2 2022 Earnings Call Transcript
Revenue
$18.29M
▲ 19.6% YoY Diluted EPS
$-0.43
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Journey Medical Corp (DERM) Q1 2022 Earnings Call Transcript
Revenue
$23.30M
▲ 117.3% YoY Diluted EPS
$-0.08
▼ 500% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-24
Journey Medical Corp (DERM) Q4 2021 Earnings Call
Revenue
$17.52M*
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Showing 1–18 of 18 webcasts